Better Therapeutics

Better Therapeutics Develops and Commercializes Digital Prescription Therapies for Cardiovascular and Metabolic Diseases with a B2B2C Business Model. They Utilize Clinically Validated, FDA-Regulated Software to Modify Behaviors that Cause These Conditions, Improving Quality of Life, Reducing Ongoing Medication Needs, and Lowering Costs. Better Therapeutics' Products Deliver Digital Behavioral Therapies, Integrating Neuroscience, Lifestyle Medicine, and Explainable Artificial Intelligence into Physician-Prescribed Mobile Medical Applications, Using Patient-Generated Data to Inform Clinical Decisions and Improve Treatment Outcomes. Better Therapeutics’ Current Pipeline Includes Candidates for Type 2 Diabetes, Hypertension, and Dyslipidemia. Nutritional Cognitive Behavioral Therapy (Nutritional-CBT), a Novel Behavioral Therapy Being Developed by Better Therapeutics, is Designed for Patients with Type 2 Diabetes and Other Cardiometabolic Disorders. Nutritional-CBT is an Adaptation of CBT Specifically Designed to Address Cognitive Patterns and Psychological Structures Driving Eating Patterns and Related Lifestyle Behaviors.